SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Peregrine Pharmaceuticals (PPHM)

Thank you but given you have not provided

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Bluerinse Member Profile
 
Followed By 9
Posts 949
Boards Moderated 0
Alias Born 09/02/11
160x600 placeholder
Peregrine Pharmaceuticals Announces Appointment of Mark R. Bamforth to Board of Directors of Peregrine and Avid Bioservices "GlobeNewswire Inc." - 10/19/2017 8:05:00 AM
Ronin Trading and SW Investment Management Announce Additional Nomination to Board of Peregrine Pharmaceuticals "PR Newswire (US)" - 10/10/2017 12:59:00 PM
CORRECTING and REPLACING Announcing VanEck Vectors Equity ETF’s September 2017 Distributions "Business Wire" - 10/2/2017 12:35:00 PM
Announcing VanEck Vectors Equity ETF’s September 2017 Distributions "Business Wire" - 9/29/2017 5:25:00 PM
Avid Bioservices Expands Manufacturing Capabilities With Installation and Validation of Two MilliporeSigma Mobius® 2,000-Lit... "GlobeNewswire Inc." - 9/25/2017 8:05:00 AM
Biotech's Recently Under the Microscope, Analyst Coverage "InvestorsHub NewsWire" - 9/20/2017 8:00:00 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 9/19/2017 2:51:59 PM
Avid Bioservices to Exhibit at 2017 BioProcess International Conference & Exhibition "GlobeNewswire Inc." - 9/19/2017 8:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/14/2017 5:21:37 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 9/14/2017 5:19:50 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 9/11/2017 5:14:45 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/11/2017 5:04:28 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 9/11/2017 5:02:13 PM
Peregrine Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018 and Recent Developments "GlobeNewswire Inc." - 9/11/2017 4:05:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/11/2017 3:37:19 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 9/11/2017 3:35:34 PM
Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D. as President of Avid Bioservices "GlobeNewswire Inc." - 9/11/2017 8:05:00 AM
Peregrine Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial Evaluating Bavituximab Treatment Combinati... "GlobeNewswire Inc." - 9/7/2017 8:10:00 AM
Peregrine to Report Financial Results for First Quarter of Fiscal Year 2018 After Market Close on September 11, 2017 "GlobeNewswire Inc." - 9/6/2017 4:05:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/5/2017 4:31:30 PM
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock "GlobeNewswire Inc." - 9/5/2017 4:05:00 PM
Proxy Statement - Contested Solicitations (preliminary) (prec14a) "Edgar (US Regulatory)" - 8/29/2017 5:23:59 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/29/2017 5:18:13 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/29/2017 5:17:43 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/29/2017 5:17:43 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist